{
    "nct_id": "NCT03217201",
    "official_title": "Systematic Light Exposure to Treat Cancer-Related Fatigue in Breast Cancer Patients",
    "inclusion_criteria": "* Newly diagnosed patients with stage 1 through 3a Breast Cancer scheduled to receive a 12-week, 16-week, 18-week, 20-week, or 24-week chemotherapy regimen, adjuvant, neoadjuvant, or already receiving chemotherapy.\n* MSH, COH and MSK can recruit participants schedule to go on aromatase inhibitors after treatment.\n* Currently over the age of 18.\n* English language proficient.\n* Able to provide informed consent.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Under age 18\n* Breast cancer patients scheduled to undergo chemo regimen other than the 12-week, 18-week, 20-week, or 24-week regimen\n* Stage 3B breast cancer inflammatory or Stage 4 breast cancer\n* Pregnancy\n* Currently employed in night shift work\n* Confounding underlying medical illnesses which may cause fatigue (e.g., severe Anemia not controlled by medication, per self-report corroborated by medical chart review (e.g., Hb<10gm/dl))\n* Eye Diseases which limit the ability of light to be processed (e.g., untreated cataracts, severe glaucoma, macular degeneration, blindness, pupil dilation problems or retina damage)\n* Secondary cancer diagnosis (prior or current) within the past 5 years\n* Severe sleep disorders (e.g., Narcolepsy)\n* Self- reported history of bipolar disorder or manic episodes (which is a contra-indication for light treatment)\n* Severe psychological impairment (e.g., hospitalization for depressive episode in the past 12 months\n* Previous use of light therapy to alleviate fatigue or depressive symptoms\n* Lives outside of the United States throughout the duration of study",
    "miscellaneous_criteria": ""
}